Management of Mitral Valve Prolapse with Tachycardia

Introduction to Mitral Valve Prolapse Management

The American College of Cardiology recommends beta-blockers as the established first-line therapy for symptomatic mitral valve prolapse patients with palpitations, shortness of breath, and tachycardia 1
No major cardiovascular guideline recommends ivabradine for mitral valve prolapse, with the 2008 ACC/AHA valvular heart disease guidelines specifically recommending beta-blockers for symptomatic MVP patients with palpitations and tachyarrhythmias 1

Ivabradine's FDA approval and guideline recommendations are restricted to heart failure with reduced ejection fraction (HFrEF with LVEF ≤35%) in patients already on maximally tolerated beta-blocker therapy with persistent heart rate ≥70 bpm 2
The drug is also approved for inappropriate sinus tachycardia (IST), a distinct condition characterized by persistently elevated resting heart rate without identifiable cause—not the episodic tachycardia and palpitations seen in MVP 3
Beta-blockers are specifically recommended for MVP patients with palpitations, mild tachyarrhythmias, chest pain, anxiety, or fatigue 1

Ivabradine is contraindicated in patients with atrial fibrillation and must be discontinued immediately if AF develops during treatment 4
Ivabradine is contraindicated in patients with atrial fibrillation and the drug works by inhibiting the If current in the sinoatrial node, which is ineffective when atrial fibrillation controls ventricular rate through AV nodal conduction 4
The American Heart Association recommends that ivabradine should not be used in patients with atrial fibrillation, as it is contraindicated 5

Eliminate stimulants: Stop caffeine, alcohol, and cigarette use before initiating pharmacotherapy, as recommended by the American College of Cardiology 1
Initiate beta-blocker therapy: Start with a cardioselective agent (metoprolol, bisoprolol) or carvedilol, titrating to symptom control, as recommended by the American College of Cardiology 1
Monitor for arrhythmias: If palpitations persist despite lifestyle modification and beta-blockers, obtain continuous or event-activated ambulatory ECG monitoring to identify specific arrhythmias requiring targeted treatment, as recommended by the American College of Cardiology 1

If orthostatic hypotension and tachycardia are prominent, treat with volume expansion through liberalized fluid and salt intake before considering mineralocorticoid therapy, as recommended by the American College of Cardiology 1
Support stockings may provide additional benefit for orthostatic symptoms, as recommended by the American College of Cardiology 1